"I am the custom tailor that goes in and makes sure the patent portfolio fits [the company] as well as possible," he said. "You can do an off-the-rack job but you will never achieve success unless you go in and establish a custom-made patent portfolio."
In July 2014, his client Seragon Pharmaceuticals Inc. was acquired by Genentech Inc., a subidiary of Roche Holding AG. ...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In